Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia.
Pediatr Blood Cancer. 2011.
PMID: 20860019
Free PMC article.
Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1946 | 1 |
| 1947 | 3 |
| 1948 | 2 |
| 1949 | 1 |
| 1950 | 2 |
| 1951 | 3 |
| 1952 | 2 |
| 1953 | 1 |
| 1954 | 1 |
| 1956 | 2 |
| 1957 | 2 |
| 1958 | 1 |
| 1959 | 2 |
| 1960 | 2 |
| 1961 | 1 |
| 1962 | 3 |
| 1963 | 6 |
| 1964 | 7 |
| 1965 | 4 |
| 1967 | 1 |
| 1969 | 1 |
| 1970 | 2 |
| 1972 | 1 |
| 1975 | 1 |
| 1976 | 2 |
| 1977 | 6 |
| 1979 | 5 |
| 1980 | 4 |
| 1981 | 5 |
| 1982 | 2 |
| 1983 | 6 |
| 1984 | 6 |
| 1985 | 9 |
| 1986 | 29 |
| 1987 | 64 |
| 1988 | 365 |
| 1989 | 706 |
| 1990 | 763 |
| 1991 | 748 |
| 1992 | 790 |
| 1993 | 784 |
| 1994 | 781 |
| 1995 | 737 |
| 1996 | 743 |
| 1997 | 761 |
| 1998 | 734 |
| 1999 | 723 |
| 2000 | 744 |
| 2001 | 740 |
| 2002 | 781 |
| 2003 | 850 |
| 2004 | 849 |
| 2005 | 951 |
| 2006 | 934 |
| 2007 | 979 |
| 2008 | 1083 |
| 2009 | 1209 |
| 2010 | 1315 |
| 2011 | 1470 |
| 2012 | 1489 |
| 2013 | 1494 |
| 2014 | 1625 |
| 2015 | 1591 |
| 2016 | 1616 |
| 2017 | 1640 |
| 2018 | 1626 |
| 2019 | 1699 |
| 2020 | 1888 |
| 2021 | 2001 |
| 2022 | 1124 |
Search Results
34,911
results
Results by year
Citations
1 article found by citation matchingSearch results
Filters applied: . Clear all
Page 1
Showing results for
body mass index and blood pressure changes over the course of treatment or pediatric acute lymphoblastic leukemia
Search for
Body Mass Index and Blood Pressure Changes over the Course of Treatment of Pediatric Acute Lymphoblastic Leukemia
instead
(1 results)
Pediatric acute lymphoblastic leukemia.
Haematologica. 2020 Nov 1;105(11):2524-2539. doi: 10.3324/haematol.2020.247031.
Haematologica. 2020.
PMID: 33054110
Free PMC article.
Review.
The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute lymphoblastic leukemia (ALL), the development of experimental models to probe mechanisms and evaluate new therapies, and the development o …
The last decade has witnessed great advances in our understanding of the genetic and biological basis of childhood acute lymphobla …
Treatment and biology of pediatric acute lymphoblastic leukemia.
Pediatr Int. 2018 Jan;60(1):4-12. doi: 10.1111/ped.13457.
Pediatr Int. 2018.
PMID: 29143423
Review.
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. ...Treatment for pediatric ALL typically consists of induction therapy with steroids, vincristine, and asparaginase with or without anthracycline, followed …
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. ...Treatment for pediatric …
Advances in adult acute lymphoblastic leukemia therapy.
Leuk Lymphoma. 2018 May;59(5):1033-1050. doi: 10.1080/10428194.2017.1354372. Epub 2017 Jul 26.
Leuk Lymphoma. 2018.
PMID: 28745565
Review.
Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently. ...In this review, we will discuss the most significant advances in treating adult ALL observed in the last five years that have the potential to …
Progress in adult acute lymphoblastic leukemia (ALL) treatment has been met with challenge until recently. ...In …
Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.
Curr Hematol Malig Rep. 2016 Oct;11(5):385-94. doi: 10.1007/s11899-016-0337-y.
Curr Hematol Malig Rep. 2016.
PMID: 27502091
Review.
While the majority of children and adolescents with newly diagnosed childhood acute lymphoblastic leukemia (ALL) will be cured, as many as 20 % of patients will experience relapse. On current treatment regimens, the intensity of upfront treatment …
While the majority of children and adolescents with newly diagnosed childhood acute lymphoblastic leukemia (ALL) will b …
Update on Lymphoblastic Leukemia/Lymphoma.
Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003.
Clin Lab Med. 2021.
PMID: 34304772
Review.
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; however, they are also encountered with significant frequency in the adult population. These neoplastic processes can be of B-cell or T …
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; ho …
Pediatric Acute Lymphoblastic Leukemia.
Oncology (Williston Park). 2019 Aug 23;33(8):683732.
Oncology (Williston Park). 2019.
PMID: 31469898
Free article.
No abstract available.
Epigenetics in pediatric acute lymphoblastic leukemia.
Semin Cancer Biol. 2018 Aug;51:129-138. doi: 10.1016/j.semcancer.2017.09.001. Epub 2017 Sep 5.
Semin Cancer Biol. 2018.
PMID: 28887175
Free article.
Review.
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ...Recent technical advances and decreasing costs of methods for high-throughput DNA sequencing and SNP genotyping have stimulated systematic studies of the epigenetic changes …
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. ...Recent technical advances and decreasi …
IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
Blood. 2020 Jan 23;135(4):252-260. doi: 10.1182/blood.2019000813.
Blood. 2020.
PMID: 31821407
Free PMC article.
Review.
Improved personalized adjustment of primary therapy to the perceived risk of relapse by using new prognostic markers for treatment stratification may be beneficial to patients with acute lymphoblastic leukemia (ALL). Here, we review the advances …
Improved personalized adjustment of primary therapy to the perceived risk of relapse by using new prognostic markers for treatment …
Genomics and pharmacogenomics of pediatric acute lymphoblastic leukemia.
Crit Rev Oncol Hematol. 2018 Jun;126:100-111. doi: 10.1016/j.critrevonc.2018.04.002. Epub 2018 Apr 10.
Crit Rev Oncol Hematol. 2018.
PMID: 29759551
Review.
Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for 70-80% of all leukemias. ...The other ALLs include Early T-cell precursor ALL, Philadelphia chromosome-like ALL, Down syndrome-associated ALL and Relap …
Acute lymphoblastic leukaemia (ALL) is a prevalent form of pediatric cancer that accounts for 70-80% of all leukemias. …
Recent Advances in Managing Acute Lymphoblastic Leukemia.
Am Soc Clin Oncol Educ Book. 2020 May;40:330-342. doi: 10.1200/EDBK_280175.
Am Soc Clin Oncol Educ Book. 2020.
PMID: 32421447
Free article.
Review.
Acute lymphoblastic leukemia (ALL) is characterized by chromosomal translocations and somatic mutations that lead to leukemogenesis. The incorporation of pediatric-type regimens has improved survival in young adults, and the incorporation of tyrosine k …
Acute lymphoblastic leukemia (ALL) is characterized by chromosomal translocations and somatic mutations that lead to le …
Cite